Skip to main content
Erschienen in: Aesthetic Plastic Surgery 4/2024

10.08.2023 | Review

Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies

verfasst von: Ioannis Kyriazidis, Georgia-Alexandra Spyropoulou, George Zambacos, Anna Tagka, Hinne A. Rakhorst, Konstantinos Gasteratos, Juan Enrique Berner, Apostolos Mandrekas

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Hyaluronic acid (HA) dermal fillers are widely used in aesthetic medicine. While generally safe, potential complications can arise.

Objective

This systematic review aims to identify and classify potential complications linked to the use of HA dermal fillers, as informed by high-quality, low-risk-of-bias studies.

Methods

This review follows the Cochrane review standards for clinical systematic reviews. This systematic review analyzed 48 high level of evidence studies on the use of hyaluronic acid (HA) dermal fillers in non-surgical facial aesthetics and the adverse events that occurred.The inclusion criteria were randomized control studies on HA dermal fillers and their complications. Excluded were case reports, case series, observational studies, and other non-randomized research due to their inability to provide generalized conclusions and their inherent publication bias.

Results

Adverse events were classified into three categories: expected reactions, product or technique-related adverse events, and severe adverse events. Most adverse events were short-lived injection site reactions, which resolved spontaneously. Specific HA fillers and injection techniques influenced the occurrence of adverse events, which generally resolved within weeks without treatment. Severe adverse events were rare, persisting for months and requiring active medical intervention.

Discussion

This classification system can enhance understanding, prevention, and treatment of HA filler complications, and support patient education. The common complications were injection site reactions, with persistent symptoms treated with topical steroids, NSAIDs, or hyaluronidase. Severe complications included severe edema, angioedema and others, often necessitating specific treatments.

Conclusion

HA dermal fillers are generally safe and effective, with most adverse events being transient and mild to moderate in severity. Severe adverse events, although rare, do occur and are generally non-treatment related. Informed consent, patient education, and professional training are crucial for safe and successful outcomes.
Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.​springer.​com/​00266.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Raspaldo H, Aziza R, Belhaouari L, Berros P et al (2011) How to achieve synergy between volume replacement and filling products for global facial rejuvenation. J Cosmet Laser Ther 2011(13):77–86CrossRef Raspaldo H, Aziza R, Belhaouari L, Berros P et al (2011) How to achieve synergy between volume replacement and filling products for global facial rejuvenation. J Cosmet Laser Ther 2011(13):77–86CrossRef
4.
Zurück zum Zitat Kablik J, Monheit GD, Yu L et al (2009) Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 35(Suppl1):302–312CrossRefPubMed Kablik J, Monheit GD, Yu L et al (2009) Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 35(Suppl1):302–312CrossRefPubMed
5.
Zurück zum Zitat Kim JE, Sykes JM (2011) Hyaluronic acid fillers: history and overview. Facial Plast Surg. 27:523–528CrossRefPubMed Kim JE, Sykes JM (2011) Hyaluronic acid fillers: history and overview. Facial Plast Surg. 27:523–528CrossRefPubMed
6.
Zurück zum Zitat Coleman SR, Grover R (2006) (2006) The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 26(1S):S4–S9CrossRefPubMed Coleman SR, Grover R (2006) (2006) The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 26(1S):S4–S9CrossRefPubMed
9.
Zurück zum Zitat Trinh LN, Gupta A (2021) Hyaluronic acid fillers for midface augmentation: a systematic review. Facial Plast Surg 37(5):576–584CrossRefPubMed Trinh LN, Gupta A (2021) Hyaluronic acid fillers for midface augmentation: a systematic review. Facial Plast Surg 37(5):576–584CrossRefPubMed
11.
13.
Zurück zum Zitat Callan P, Goodman GJ, Carlisle I, Liew S, Muzikants P, Scamp T, Halstead MB, Rogers JD (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmetic Investig Dermatol 6:81–89. https://doi.org/10.2147/CCID.S40581CrossRef Callan P, Goodman GJ, Carlisle I, Liew S, Muzikants P, Scamp T, Halstead MB, Rogers JD (2013) Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmetic Investig Dermatol 6:81–89. https://​doi.​org/​10.​2147/​CCID.​S40581CrossRef
18.
Zurück zum Zitat Goodman GJ, Bekhor P, Rich M, Rosen RH, Halstead MB, Rogers JD (2011) A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds: a multicenter, prospective, randomized, controlled, single-blind, within-subject study. Clin Cosmet Investig Dermatol 4:197–205. https://doi.org/10.2147/CCID.S26055CrossRefPubMedPubMedCentral Goodman GJ, Bekhor P, Rich M, Rosen RH, Halstead MB, Rogers JD (2011) A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds: a multicenter, prospective, randomized, controlled, single-blind, within-subject study. Clin Cosmet Investig Dermatol 4:197–205. https://​doi.​org/​10.​2147/​CCID.​S26055CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Duranti F, Salti G, Bovani B et al (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 24:1317–25CrossRefPubMed Duranti F, Salti G, Bovani B et al (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 24:1317–25CrossRefPubMed
21.
Zurück zum Zitat Friedman PM, Mafong EA, Kauvar AN et al (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28:491–4PubMed Friedman PM, Mafong EA, Kauvar AN et al (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28:491–4PubMed
24.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG,Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009;6(7). Moher D, Liberati A, Tetzlaff J, Altman DG,Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009;6(7).
26.
Zurück zum Zitat Lowe NJ, Maxwell CA, Patnaik R (2005) Adverse reactions to dermal fillers. Dermatol Surg 31:1626–1633CrossRef Lowe NJ, Maxwell CA, Patnaik R (2005) Adverse reactions to dermal fillers. Dermatol Surg 31:1626–1633CrossRef
27.
Zurück zum Zitat DeLorenzi C (2013) Complications of Injectable Fillers Part I. Aesthet Surg J 33(4):561–575CrossRefPubMed DeLorenzi C (2013) Complications of Injectable Fillers Part I. Aesthet Surg J 33(4):561–575CrossRefPubMed
31.
Zurück zum Zitat Sundaram H, Shamban A, Schlessinger J, Kaufman-Janette J, Joseph JH, Lupin M, Draelos Z, Carey W, Smith S, Eaton L (2022) Efficacy and safety of a new resilient hyaluronic acid filler in the correction of moderate-to-severe dynamic perioral rhytides: a 52-week prospective, multicenter, controlled, randomized Evaluator-Blinded Study. Dermatol Surg 48(1):87–93. https://doi.org/10.1097/DSS.0000000000003238CrossRefPubMed Sundaram H, Shamban A, Schlessinger J, Kaufman-Janette J, Joseph JH, Lupin M, Draelos Z, Carey W, Smith S, Eaton L (2022) Efficacy and safety of a new resilient hyaluronic acid filler in the correction of moderate-to-severe dynamic perioral rhytides: a 52-week prospective, multicenter, controlled, randomized Evaluator-Blinded Study. Dermatol Surg 48(1):87–93. https://​doi.​org/​10.​1097/​DSS.​0000000000003238​CrossRefPubMed
34.
Zurück zum Zitat Monheit G, Kaufman-Janette J, Joseph JH, Shamban A, Dover JS, Smith S (2020) Efficacy and safety of two resilient hyaluronic acid fillers in the treatment of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blinded, and within-subject study. Dermatol Surg 46(12):1521–1529. https://doi.org/10.1097/DSS.0000000000002391CrossRefPubMed Monheit G, Kaufman-Janette J, Joseph JH, Shamban A, Dover JS, Smith S (2020) Efficacy and safety of two resilient hyaluronic acid fillers in the treatment of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blinded, and within-subject study. Dermatol Surg 46(12):1521–1529. https://​doi.​org/​10.​1097/​DSS.​0000000000002391​CrossRefPubMed
39.
Zurück zum Zitat Jung JM, Lee WS, Kim HT, Moon YS, Paik SH, Lee WJ, Chang SE, Lee MW, Won CJ, Kim BJ (2019) A multi-center, randomized, double blinded, comparative study of two hyaluronic acid fillers for temporary restoration of mid-face volume in Asians. J Cosmet Dermatol. 00:1–8. https://doi.org/10.1111/jocd.13218CrossRef Jung JM, Lee WS, Kim HT, Moon YS, Paik SH, Lee WJ, Chang SE, Lee MW, Won CJ, Kim BJ (2019) A multi-center, randomized, double blinded, comparative study of two hyaluronic acid fillers for temporary restoration of mid-face volume in Asians. J Cosmet Dermatol. 00:1–8. https://​doi.​org/​10.​1111/​jocd.​13218CrossRef
45.
Zurück zum Zitat Jeong KH, Gwak MJ, Moon SK, Lee SJ, Shin MK (2018) Efficacy and durabil- ity of hyaluronic acid fillers for malar enhancement: a prospective, randomized, split-face clinical controlled trial. J Cosmet Laser Ther. 20(3):184–188CrossRefPubMed Jeong KH, Gwak MJ, Moon SK, Lee SJ, Shin MK (2018) Efficacy and durabil- ity of hyaluronic acid fillers for malar enhancement: a prospective, randomized, split-face clinical controlled trial. J Cosmet Laser Ther. 20(3):184–188CrossRefPubMed
47.
50.
Zurück zum Zitat Nikolis A, Enright KM, Öhrlund Å, Winlöf P, Cotofana S (2021) A randomized, split-face, double-blind, comparative study of the safety and efficacy of small- and large-particle hyaluronic acid fillers for the treatment of nasolabial folds. J Cosmet Dermatol 20(5):1450–1458. https://doi.org/10.1111/jocd.13668CrossRefPubMed Nikolis A, Enright KM, Öhrlund Å, Winlöf P, Cotofana S (2021) A randomized, split-face, double-blind, comparative study of the safety and efficacy of small- and large-particle hyaluronic acid fillers for the treatment of nasolabial folds. J Cosmet Dermatol 20(5):1450–1458. https://​doi.​org/​10.​1111/​jocd.​13668CrossRefPubMed
55.
Zurück zum Zitat Rhee, doY., Won, C. H., Chang, S. E., Noh, T. K., Kim, M. S., Kim, B. J., Park, G. H., An, J. S., Lee, M. W., Choi, J. H., Moon, K. C., & Lim, S. H. (2014) Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study. J Dermatol Treat 25(5):448–452. https://doi.org/10.3109/09546634.2013.814756CrossRef Rhee, doY., Won, C. H., Chang, S. E., Noh, T. K., Kim, M. S., Kim, B. J., Park, G. H., An, J. S., Lee, M. W., Choi, J. H., Moon, K. C., & Lim, S. H. (2014) Efficacy and safety of a new monophasic hyaluronic acid filler in the correction of nasolabial folds: a randomized, evaluator-blinded, split-face study. J Dermatol Treat 25(5):448–452. https://​doi.​org/​10.​3109/​09546634.​2013.​814756CrossRef
57.
Zurück zum Zitat Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M (2011) Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Therapy 13(3):107–112. https://doi.org/10.3109/14764172.2011.571699CrossRef Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M (2011) Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Therapy 13(3):107–112. https://​doi.​org/​10.​3109/​14764172.​2011.​571699CrossRef
67.
Zurück zum Zitat Hu Y, Liu Z, Wang Y et al (2022) Efficacy and safety of two hyaluronic acid fillers with different injection depths for the correction of moderate-to-severe nasolabial folds: A 52-week, prospective, randomized, double-blinded study in a Chinese population. J Cosmet Dermatol. 21:940–948. https://doi.org/10.1111/jocd.14744CrossRefPubMed Hu Y, Liu Z, Wang Y et al (2022) Efficacy and safety of two hyaluronic acid fillers with different injection depths for the correction of moderate-to-severe nasolabial folds: A 52-week, prospective, randomized, double-blinded study in a Chinese population. J Cosmet Dermatol. 21:940–948. https://​doi.​org/​10.​1111/​jocd.​14744CrossRefPubMed
68.
Zurück zum Zitat Prager W, Agsten K, Kravtsov M, Kerscher PM (2017) Mid-face volumization with hyaluronic acid: injection technique and safety aspects from a controlled, randomized, double-blind clinical study. J Drugs Dermatol JDD 16(4):351–357PubMed Prager W, Agsten K, Kravtsov M, Kerscher PM (2017) Mid-face volumization with hyaluronic acid: injection technique and safety aspects from a controlled, randomized, double-blind clinical study. J Drugs Dermatol JDD 16(4):351–357PubMed
70.
Zurück zum Zitat Jung JM, Lee WS, Yoon J, Paik SH, Han HS, Lee WJ, Chang SE, Won CH, Kim BJ (2021) A multicenter, randomized, double-blind comparison of two hyaluronic acid fillers in mid-face volume restoration in Asians: A 2-year extension study. Dermatol Therapy 34(2):e14787. https://doi.org/10.1111/dth.14787CrossRef Jung JM, Lee WS, Yoon J, Paik SH, Han HS, Lee WJ, Chang SE, Won CH, Kim BJ (2021) A multicenter, randomized, double-blind comparison of two hyaluronic acid fillers in mid-face volume restoration in Asians: A 2-year extension study. Dermatol Therapy 34(2):e14787. https://​doi.​org/​10.​1111/​dth.​14787CrossRef
71.
Zurück zum Zitat Wu Y, Xu J, Jia Y, Murphy DK (2016) Safety and effectiveness of hyaluronic acid injectable gel in correcting moderate nasolabial folds in chinese subjects. J Drugs Dermatol JDD 15(1):70–76PubMed Wu Y, Xu J, Jia Y, Murphy DK (2016) Safety and effectiveness of hyaluronic acid injectable gel in correcting moderate nasolabial folds in chinese subjects. J Drugs Dermatol JDD 15(1):70–76PubMed
Metadaten
Titel
Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies
verfasst von
Ioannis Kyriazidis
Georgia-Alexandra Spyropoulou
George Zambacos
Anna Tagka
Hinne A. Rakhorst
Konstantinos Gasteratos
Juan Enrique Berner
Apostolos Mandrekas
Publikationsdatum
10.08.2023
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 4/2024
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-023-03465-1

Weitere Artikel der Ausgabe 4/2024

Aesthetic Plastic Surgery 4/2024 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.